Patient characteristics
. | No. patients (%) . | Median . | Range . |
|---|---|---|---|
| Age, y | 302 | 65 | 29-94 |
| Sex | |||
| Male | 180 (60) | NA | NA |
| Female | 123 (40) | NA | NA |
| B2M, mg/L | 275 | 3.68 | 0.98-63.8 |
| LDH, U/L | 275 | 141 | 60-963 |
| CRP, mg/dL | 249 | 0.4 | 0.01-20.00 |
| Albumin level, g/dL | 302 | 3.6 | 1.8-5.4 |
| PC labeling index, % | |||
| Less than 1 (low) | 172 | NA | NA |
| 1 or more (high) | 84 | NA | NA |
| BM PC, % | 255 | 45 | 11-90 |
| ISS stage | |||
| I | 69 (26) | NA | NA |
| II | 128 (42) | NA | NA |
| III | 78 (26) | NA | NA |
| Unknown | 28 (9) | NA | NA |
. | No. patients (%) . | Median . | Range . |
|---|---|---|---|
| Age, y | 302 | 65 | 29-94 |
| Sex | |||
| Male | 180 (60) | NA | NA |
| Female | 123 (40) | NA | NA |
| B2M, mg/L | 275 | 3.68 | 0.98-63.8 |
| LDH, U/L | 275 | 141 | 60-963 |
| CRP, mg/dL | 249 | 0.4 | 0.01-20.00 |
| Albumin level, g/dL | 302 | 3.6 | 1.8-5.4 |
| PC labeling index, % | |||
| Less than 1 (low) | 172 | NA | NA |
| 1 or more (high) | 84 | NA | NA |
| BM PC, % | 255 | 45 | 11-90 |
| ISS stage | |||
| I | 69 (26) | NA | NA |
| II | 128 (42) | NA | NA |
| III | 78 (26) | NA | NA |
| Unknown | 28 (9) | NA | NA |
NA indicates not applicable.